Indications
- xxx
Pharmacology
- Glycoengineered Type II Monoclonal Antibody Against B-Cell CD20 (see Anti-CD20 Therapy, [[Anti-CD20 Therapy]])
Metabolism
- xxx
Administration
- xxx
Dose Adjustment
- Hepatic: xxx
- Renal: xxx
Adverse Effects
Other Adverse Effects
- xxx
- xxx
- xxx
- xxx
References
- xxx